Raj Nagaraja, Ph.D.

Raj comes from Servier Pharmaceuticals where he worked as the Senior Director and Head of DMPK (US). He has over 20 years of experience in the field of DMPK at top pharma companies (Servier, Agios Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Millennium Pharmaceuticals/Takeda, and DuPont/Bristol Myers Squibb). He has experience in both small and large molecules DMPK in exploratory research, lead optimization, IND filing, and in various capacities in clinical trial phases. Raj has successfully incorporated the translational biomarkers in several drug discovery and development programs. His research interests are Discovery and Development DMPK, Clinical Pharmacology, and PKPD modeling and simulations. Raj has co-authored/co-invented more than 30 peer-reviewed publications and patents.

Raj obtained his B.S. and M.S. in Pharmacy, a Ph.D. in Pharmacokinetics and Drug Metabolism from Central Drug Research Institute, India, and did Postdoctoral research at University of Florida.

I accept The Ensem Therapeutics Privacy Policy

Subscribe